Enveric Biosciences, Inc.
ENVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000890821
No open-market purchases or sales by Enveric Biosciences, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $736.8K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Enveric Biosciences, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 17 | 19 | +2 |
| Shares | 711.3K | 1.08M | +367.8K (+51.7%) |
| Value | $337.2K | $386.7K | +$49.5K (+14.7%) |
New holders (3)
Institutions that held Enveric Biosciences, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 22,007 | $7.89K | 0.00% |
| Jane Street Group, LLC | 10,815 | $3.88K | 0.00% |
| SBI Securities Co., Ltd. | 19 | $7 | 0.00% |
Sold out (1)
Institutions that held Enveric Biosciences, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Advisor Group Holdings, Inc. | 575 | $271 |